These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25851544)

  • 41. Temporal application of topography to increase the rate of neural differentiation from human pluripotent stem cells.
    Chan LY; Birch WR; Yim EK; Choo AB
    Biomaterials; 2013 Jan; 34(2):382-92. PubMed ID: 23083932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine.
    Mitsui K; Ide K; Takahashi T; Kosai KI
    Mol Ther Methods Clin Dev; 2017 Jun; 5():51-58. PubMed ID: 28480304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation and purification of ACTH-secreting hPSC-derived pituitary cells for effective transplantation.
    Taga S; Suga H; Nakano T; Kuwahara A; Inoshita N; Kodani Y; Nagasaki H; Sato Y; Tsumura Y; Sakakibara M; Soen M; Miwata T; Ozaki H; Kano M; Watari K; Ikeda A; Yamanaka M; Takahashi Y; Kitamoto S; Kawaguchi Y; Miyata T; Kobayashi T; Sugiyama M; Onoue T; Yasuda Y; Hagiwara D; Iwama S; Tomigahara Y; Kimura T; Arima H
    Stem Cell Reports; 2023 Aug; 18(8):1657-1671. PubMed ID: 37295423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deploying human pluripotent stem cells to treat central nervous system disorders: facts, challenges and realising the potential.
    Allsopp TE; Ebneth A; Cabrera-Socorro A
    Stem Cell Res; 2019 Dec; 41():101581. PubMed ID: 31812872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generating functional cells through enhanced interspecies chimerism with human pluripotent stem cells.
    Zhu Y; Zhang Z; Fan N; Huang K; Li H; Gu J; Zhang Q; Ouyang Z; Zhang T; Tang J; Zhang Y; Suo Y; Lai C; Wang J; Wang J; Shan Y; Wang M; Chen Q; Zhou T; Lai L; Pan G
    Stem Cell Reports; 2022 May; 17(5):1059-1069. PubMed ID: 35427483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges.
    Gao Y; Pu J
    Front Cell Dev Biol; 2021; 9():658088. PubMed ID: 34055788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cells, neural progenitors, and engineered stem cells.
    Rao RR; Iyer S
    Methods Mol Biol; 2015; 1254():255-67. PubMed ID: 25431071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Closed-channel culture system for efficient and reproducible differentiation of human pluripotent stem cells into islet cells.
    Hirano K; Konagaya S; Turner A; Noda Y; Kitamura S; Kotera H; Iwata H
    Biochem Biophys Res Commun; 2017 May; 487(2):344-350. PubMed ID: 28412348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondria in human pluripotent stem cell apoptosis.
    TeSlaa T; Setoguchi K; Teitell MA
    Semin Cell Dev Biol; 2016 Apr; 52():76-83. PubMed ID: 26828436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
    Zheng H; Chen Y; Luo Q; Zhang J; Huang M; Xu Y; Huo D; Shan W; Tie R; Zhang M; Qian P; Huang H
    Cell Regen; 2023 Sep; 12(1):31. PubMed ID: 37656237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges.
    Liu LP; Zheng YW
    World J Stem Cells; 2019 Jul; 11(7):375-382. PubMed ID: 31396366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precise immune tolerance for hPSC derivatives in clinical application.
    Zhu W; Li M; Wu Y; Hu B
    Cell Immunol; 2018 Apr; 326():15-23. PubMed ID: 28866278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.
    Sart S; Liu C; Zeng EZ; Xu C; Li Y
    Eng Life Sci; 2022 Nov; 22(11):667-680. PubMed ID: 36348655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3D Human Esophageal Epithelium Steps Out from hPSCs.
    Rustgi AK
    Cell Stem Cell; 2018 Oct; 23(4):460-462. PubMed ID: 30290173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
    Krivec N; Ghosh MS; Spits C
    Stem Cell Reports; 2024 Jan; 19(1):11-27. PubMed ID: 38157850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating human pluripotent stem cells into drug development.
    Engle SJ; Puppala D
    Cell Stem Cell; 2013 Jun; 12(6):669-77. PubMed ID: 23746976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of Homogeneous Populations of Cortical Interneurons from Human Pluripotent Stem Cells.
    Ni P; Fan L; Zinski A; Chung S
    Methods Mol Biol; 2023; 2683():13-20. PubMed ID: 37300763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining synthetic surfaces for human pluripotent stem cell culture.
    Lambshead JW; Meagher L; O'Brien C; Laslett AL
    Cell Regen; 2013; 2(1):7. PubMed ID: 25408879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in human pluripotent stem cell reporter systems.
    Puspita L; Juwono VB; Shim JW
    iScience; 2024 Sep; 27(9):110856. PubMed ID: 39290832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemical ablation of tumor-initiating human pluripotent stem cells.
    Ben-David U; Benvenisty N
    Nat Protoc; 2014 Mar; 9(3):729-40. PubMed ID: 24577362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.